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NOTICE TO READERS 
The American Institute of Certified Public Accountants has issued 
a series of industry-oriented audit guides that present recommenda-
tions on auditing procedures and auditors' reports and, in some 
instances, on accounting principles, and a series of accounting guides 
that present recommendations on accounting principles. Based on 
experience in the application of these guides, AICPA subcommittees 
or task forces may from time to time conclude that it is desirable to 
change a guide. A statement of position is used to revise or clarify 
certain of the recommendations in the guide to which it relates. A 
statement of position represents the considered judgment of the re-
sponsible AICPA subcommittee or task force. 
To the extent that a statement of position is concerned with 
auditing procedures and auditors' reports, its degree of authority is 
the same as that of the audit guide to which it relates. As to such 
matters, members should be aware that they may be called upon to 
justify departures from the recommendations of the subcommittee or 
task force. 
To the extent that a statement of position relates to standards of 
financial accounting or reporting (accounting principles), the recom-
mendations of the subcommittee or task force are subject to ultimate 
disposition by the Financial Accounting Standards Board. The recom-
mendations are made for the purpose of urging the FASB to promul-
gate standards that the subcommittee or task force believes would be 
in the public interest. 
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May 1, 1978 
Donald J. Kirk, CPA 
Chairman 
Financial Accounting Standards Board 
High Ridge Park 
Stamford, Connecticut 06905 
Dear Mr. Kirk: 
The accompanying statement of position, prepared by the 
AICPA Subcommittee on Health Care Matters, proposes 
amendments to the AICPA Industry Audit Guide on 
Audits of Hospitals. The statement of position will 
amend part of chapter 2 of the guide which deals with 
investment income and gains (losses). 
Members of the subcommittee will be glad to meet with 
you or your representatives to discuss this proposal. 
The subcommittee would also appreciate being advised as 
to the board's proposed action on its recommendations. 
Sincerely yours, 
Albert A. Cardone, Chairman 
Subcommittee on Health 
Care Matters 
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Accounting by Hospitals for 
Certain Marketable Equity Securities 
Statement of Financial Accounting Standards no. 12, Accounting 
for Certain Marketable Securities, issued by the Financial Ac-
counting Standards Board, states in the first sentence of para-
graph 5 that it "does not apply to not-for-profit organizations," 
which are those described in the Introduction to Accounting Re-
search Bulletin no. 43. Thus, FASB Statement no. 12 applies to 
investor-owned hospitals and does not apply to not-for-profit 
hospitals. 
The AICPA Subcommittee on Health Care Matters believes 
that the Hospital Audit Guide should be amended by deletion of 
the section "Investment Income and Gains (Losses)" and inclu-
sion of the following new section. 
Accounting for Certain Marketable Equity Securities 
Investor-owned hospitals are subject to the requirements of 
FASB Statement no. 12 and interpretations of that statement, 
which specify the accounting and disclosure requirements ap-
plicable to portfolios of marketable equity securities. Under 
statement no. 12, cost is no longer an acceptable accounting 
method for marketable equity securities, and the carrying amount 
of a marketable equity security portfolio that was previously 
carried at cost should now be the lower of its aggregate cost 
and market values.1 
Similarly, cost should no longer be used by not-for-profit hospitals 
for marketable equity securities. The carrying amount of a mar-
1 Reference should be made to paragraph 7 of FASB Statement no. 12 for 
definitions of the following terms: equity security, marketable, market 
price, market value, cost, valuation allowance, carrying amount, realized 
gain or loss, net unrealized gain or loss. 
5 
ketable equity security portfolio of a not-for-profit hospital that 
was previously carried at cost should now be the lower of its 
aggregate cost and market value, determined at the balance 
sheet date. The amounts by which the aggregate cost of each 
portfolio exceeds market value should be accounted for as valua-
tion allowances. 
Marketable equity securities owned by a not-for-profit hospital 
should be grouped into separate portfolios, as indicated below, for 
the purpose of comparing aggregate cost and market value to 
determine carrying amount. 
1. Marketable equity securities included in unrestricted funds 
should be grouped into separate portfolios according to the 
current or noncurrent classification of the securities. 
2. Marketable equity securities included in different types of 
restricted funds should be grouped into separate portfolios 
according to types of funds (for example, portfolios of mar-
ketable equity securities included in various specific purpose 
funds should be grouped together but not with those in en-
dowment funds). 
3. The current portfolios of unrestricted funds of entities that are 
combined in financial statements should be treated as a single 
combined portfolio; the noncurrent unrestricted portfolios of 
those entities should also be treated as a single combined port-
folio; similar restricted fund portfolios of entities that are 
combined in financial statements should be treated as single 
portfolios (for example, portfolios of marketable equity 
securities included in the various specific purpose funds 
of a not-for-profit hospital should be combined with the 
portfolios of marketable equity securities held in the various 
specific purpose funds of an entity whose financial statements 
are combined with those of the not-for-profit hospital). 
If there is a change in a marketable equity security's classifica-
tion between current and noncurrent assets in unrestricted funds, 
the security should be transferred between the corresponding port-
folios at the lower of its cost and market values at the date of trans-
fer. If market value is less than cost, the market value becomes 
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the new cost basis, and the difference is accounted for as if it were 
a realized loss and is included in the nonoperating revenues sec-
tion of the statement of revenues and expenses. 
Changes in the valuation allowance for a marketable equity 
securities portfolio included in current assets in unrestricted funds 
should be disclosed in the nonoperating revenues section of the 
statement of revenues and expenses. Changes in the valuation 
allowance for a marketable equity securities portfolio included in 
noncurrent assets in unrestricted funds or assets in restricted funds 
should be disclosed in the respective statements of changes in fund 
balances; accumulated changes in the valuation allowance for such 
portfolios should be disclosed in the appropriate fund balance in 
the balance sheet. 
If the hospital pools its investments (which could include in-
vestments of current and noncurrent unrestricted funds and in-
vestments of restricted funds), the cost of marketable equity 
securities in the fund(s) should be compared to the allocation of 
the market value of the pooled marketable equity securities for 
purposes of implementing the above recommendations. To apply 
those provisions properly, marketable equity securities and other 
investments must be accounted for separately. 
Income from investments of board-designated and other unre-
stricted funds and realized gains or losses on sales of investments 
of board-designated and other unrestricted funds should be in-
cluded in the statement of revenues and expenses as nonoperating 
revenue of the period in which they are earned or incurred. 
Realized gains or losses on the sale of investments of endow-
ment funds should be added to or deducted from endowment 
fund principal unless such amounts are legally available for other 
use or chargeable against other funds. Investment income of those 
funds should be accounted for in accordance with the donors' 
instructions—for example, as resources for specific operating pur-
poses if restricted, or nonoperating revenue if not. 
Income and net realized gains or losses on investments of re-
stricted funds other than endowment funds should be charged 
or credited to the respective fund balance unless such amounts 
are legally available for or chargeable against other funds. If such 
amounts are legally available for unrestricted purposes, they should 
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be included in nonoperating revenue. Gains or losses on invest-
ment trading between unrestricted and restricted funds and be-
tween various categories of restricted funds (for example, between 
endowment and plant replacement funds) should be recognized 
as realized gains or losses and separately disclosed in the financial 
statements. Gains or losses resulting from transactions between 
various board-designated funds of the unrestricted fund should 
not be recognized. 
The following information with respect to owned marketable 
equity securities should also be disclosed either in the body of 
the financial statements or in the accompanying notes: 
1. As of the date of each balance sheet presented, aggregate cost 
and market values for each separate portfolio into which mar-
ketable equity securities were grouped to determine carrying 
amount, with identification of which is the carrying amount. 
2. As of the date of the latest balance sheet presented, the fol-
lowing segregated by portfolio— 
a. Gross unrealized gains representing the excess of market 
value over cost for all marketable equity securities having 
such an excess in the portfolio. 
b. Gross unrealized losses representing the excess of cost over 
market value for all marketable equity securities having 
such an excess in the portfolio. 
3. For each period for which a statement of revenues and ex-
penses is presented— 
a. Net realized gain or loss included in nonoperating revenue. 
b. The basis on which cost was determined in computing real-
ized gain or loss (average cost or other method). 
The financial statements should not be adjusted for realized 
gains, losses, or changes in market prices with respect to market-
able equity securities if such gains, losses, or changes occur 
after the date of the financial statements but before their issuance, 
except for the situation covered in the following paragraph. How-
ever, significant net realized and net unrealized gains and losses 
arising after the date of the financial statements but before their 
issuance applicable to marketable equity securities owned at the 
date of the most recent balance sheet should be disclosed. 
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For those marketable securities for which the effect of a change 
in carrying amount is included in the statement of changes in fund 
balances rather than in the statement of revenues and expenses, a 
determination should be made as to whether a decline in market 
value below cost as of the balance sheet date of an individual 
security is other than temporary. If the decline is judged to be 
other than temporary, the cost basis of the individual security 
should be written down to a new cost basis and the amount of the 
write-down should be accounted for as a realized loss. The new 
cost basis should not be changed for subsequent recoveries in 
market value. 
Unrealized gains or losses should not result in adjustment of 
financial statements, except for changes in the valuation allow-
ance related to marketable equity securities and for declines in 
value that result from other than temporary impairment. 
The disclosures in Note 1 to the sample financial statements on 
page 48 of the Hospital Audit Guide should conform with the 
disclosures set forth in this amendment. 
Transition 
The subcommittee recommends that this amendment be ap-
plied to financial statements for fiscal years beginning on or after 
the first day of the first month following the date of this state-
ment and encourages earlier application. If the initial application 
of this statement requires the establishment of a valuation allow-
ance, financial statements previously issued should not be restated. 
If the establishment of a valuation allowance is required for a mar-
ketable equity securities portfolio included in current assets in un-
restricted funds, the effect of the change should be included in the 
determination of the excess of revenue over expense for the period 
of the change in accordance with the provisions of APB Opinion 
20. If the establishment of a valuation allowance is required for a 
marketable equity securities portfolio included in noncurrent as-
sets in unrestricted funds or assets in restricted funds, the effect of 
the change should be presented in the statement of changes in 
fund balance. 
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